Skip to content
The Nexus
DossierENTITY

Harbin Pharmaceutical Group

Coverage of Harbin Pharmaceutical Group in the Nexus archive.

Earliest in view: Jul 17 · 02:40 UTCMost recent: Jul 19 · 22:00 UTC
Co-mentioned in this coverage
Zhang Yichenperson2Citic Capital Holdingsorganization2Trustar Capitalorganization2McDonald’s master franchise businessorganization2Hong Kong Exchanges and Clearingorganization2Buyout Fundstopic1IPOstopic1Two Sessionstopic1
Recent coverage
  • BUSINESSJul 19 · 22:00 UTCSCMP WORLD
    Why buyout funds, not IPOs, may define China’s next capital market cycle: Zhang Yichen

    Zhang Yichen, chairman of Citic Capital Holdings and Trustar Capital, argues that buyout funds may play a more significant role than IPOs in shaping China’s next capital market cycle. He leads companies including McDonald’s master franchise business in China and Hong Kong and Harbin Pharmaceutical Group, and serves on the board of Hong Kong Exchanges and Clearing (HKEX).

  • BUSINESSJul 17 · 02:40 UTCSCMP WORLD
    Citic Capital CEO on making China a financial powerhouse

    Zhang Yichen, CEO of Citic Capital Holdings and chairman of Trustar Capital, leads several companies including McDonald’s master franchise business in China and Hong Kong, Harbin Pharmaceutical Group, and serves on the board of Hong Kong Exchanges and Clearing (HKEX). The interview was conducted during China’s annual 'two sessions' meetings.